Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red de Cáncer (61)

2023

  1. A Multimodal Scaffold for SDF1 Delivery Improves Cardiac Function in a Rat Subacute Myocardial Infarct Model

    ACS Applied Materials and Interfaces, Vol. 15, Núm. 44, pp. 50638-50651

  2. Alginate sulfate-nanoparticles loaded with hepatocyte growth factor and insulin-like growth factor-1 improve left ventricular repair in a porcine model of myocardial ischemia reperfusion injury

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 184, pp. 83-91

  3. An engineered periosteum for efficient delivery of rhBMP-2 and mesenchymal progenitor cells during bone regeneration

    npj Regenerative Medicine, Vol. 8, Núm. 1

  4. CC-Chemokine Receptor-2 Expression in Osteoblasts Contributes to Cartilage and Bone Damage during Post-Traumatic Osteoarthritis

    Biomolecules, Vol. 13, Núm. 6

  5. Endothelial NOX5 overexpression induces changes in the cardiac gene profile: potential impact in myocardial infarction?

    Journal of Physiology and Biochemistry, Vol. 79, Núm. 4, pp. 787-797

  6. Epigenome profiling reveals aberrant DNA methylation signature in GATA2 deficiency

    Haematologica, Vol. 108, Núm. 9, pp. 2551-2557

  7. FOXP3 expression diversifies the metabolic capacity and enhances the efficacy of CD8 T cells in adoptive immunotherapy of melanoma

    Molecular Therapy, Vol. 31, Núm. 1, pp. 48-65

  8. Gene therapy restores the transcriptional program of hematopoietic stem cells in Fanconi anemia

    Haematologica, Vol. 108, Núm. 10, pp. 2652-2663

  9. Generation of heart and vascular system in rodents by blastocyst complementation

    Developmental Cell, Vol. 58, Núm. 24, pp. 2881-2895.e7

  10. Identification and experimental validation of druggable epigenetic targets in hepatoblastoma

    Journal of Hepatology, Vol. 79, Núm. 4, pp. 989-1005

  11. Lipid nanoparticles for siRNA delivery in cancer treatment

    Journal of Controlled Release, Vol. 361, pp. 130-146

  12. Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia

    Frontiers in Immunology, Vol. 14